high blood pressure and glp 1 Potential Use of GLP-1 GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at? RNA sequencing reveals link between

At Family Health Care, our experienced healthcare professionals administer injections in-office, which may include additional professional fees compared to self-injection at home

Insulin or sulfonylureas may increase hypoglycemia risk when combined with GLP-1 agents, often requiring dose adjustments

Mounjaro (tirzepatide), part of the next generation of GLP-1 + GIP medications, has raised the bar further, with average weight loss hovering around 17% , and 57% of users losing more than 20% of their bodyweight 9

Remember, the risks of stopping Eliquis are immediate and potentially life-threatening

Potential Benefits Stimulates endogenous pulsatile GH release, supporting physiologic IGF1 elevation [1] [2]